New YorkA 52852025-2026 Regular SessionHouseWALLET

Relates to prescription labels for mifepristone and misoprostol

Sponsored By: Karines Reyes (Democratic)

Became Law

HIGHER EDUCATIONRULES

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Clinic name on mifepristone, misoprostol labels

The law lets labels for mifepristone and misoprostol (and generics) show the clinic or dispensing practice name and address instead of an individual’s name. At a prescriber’s request, the label uses the prescribing practice name or address instead of the prescriber’s name, and pharmacies must follow it. Prescribers must tell the patient when they use or request this practice-based labeling.

Sponsors & Cosponsors

Sponsor

Karines Reyes
Democratic • House

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 40 • No: 21

House vote • 3/10/2025

FLOOR Vote